BERLIN (Reuters) – Swiss drugmaker Roche on Wednesday said the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-testing kit.
Screening for HPV can help identify women who are at risk of developing cervical cancer at an earlier stage.
(Reporting by Rachel More, writing by Andrey Sychev)
Copyright 2024 Thomson Reuters.
Photos You Should See – May 2024
